| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | 1.38e-04 | 739 | 32 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 2.18e-04 | 187 | 32 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 3.75e-04 | 18 | 32 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.34e-03 | 303 | 32 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.35e-03 | 34 | 32 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.86e-03 | 562 | 32 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | cadherin binding | 2.02e-03 | 339 | 32 | 4 | GO:0045296 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 2.05e-03 | 1160 | 32 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.46e-03 | 599 | 32 | 5 | GO:0050839 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 3.04e-03 | 1244 | 32 | 7 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 3.43e-03 | 1271 | 32 | 7 | GO:0000987 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.24e-03 | 417 | 32 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 4.29e-03 | 61 | 32 | 2 | GO:0030374 | |
| GeneOntologyMolecularFunction | mRNA binding | 4.62e-03 | 694 | 32 | 5 | GO:0003729 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 4.91e-03 | 1356 | 32 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 7.30e-03 | 1459 | 32 | 7 | GO:0000977 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F | 5.79e-20 | 44 | 33 | 10 | GO:0048026 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F | 1.91e-19 | 49 | 33 | 10 | GO:0050685 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F SON | 6.74e-19 | 129 | 33 | 12 | GO:0048024 |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F | 2.93e-18 | 63 | 33 | 10 | GO:0033120 |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F SON | 8.25e-18 | 158 | 33 | 12 | GO:0050684 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F SON | 2.23e-16 | 207 | 33 | 12 | GO:0043484 |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 THRAP3 RC3H1 RBMX RBMY1A1 RBMY1C RBMY1F SON | 6.74e-14 | 443 | 33 | 13 | GO:1903311 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 THRAP3 RC3H1 RBMX RBMY1A1 RBMY1C RBMY1F | 1.50e-13 | 259 | 33 | 11 | GO:1903313 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F SON | 1.59e-13 | 358 | 33 | 12 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F SON | 1.59e-13 | 358 | 33 | 12 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F SON | 1.82e-13 | 362 | 33 | 12 | GO:0000375 |
| GeneOntologyBiologicalProcess | RNA splicing | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F SON | 8.46e-12 | 502 | 33 | 12 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA processing | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F SON | 2.50e-11 | 551 | 33 | 12 | GO:0006397 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 THRAP3 RC3H1 RBMX RBMY1A1 RBMY1C RBMY1F SON | 6.11e-10 | 917 | 33 | 13 | GO:0016071 |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | RBMY1D RBMY1B RBMY1E KAT7 CTNNB1 RBMXL3 ARID1A RBMXL1 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F | 1.42e-07 | 1446 | 33 | 13 | GO:0010628 |
| GeneOntologyBiologicalProcess | male sex differentiation | 6.67e-07 | 199 | 33 | 6 | GO:0046661 | |
| GeneOntologyBiologicalProcess | RNA processing | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 THRAP3 RBMX RBMY1A1 RBMY1C RBMY1F SON | 1.76e-06 | 1500 | 33 | 12 | GO:0006396 |
| GeneOntologyBiologicalProcess | reproductive structure development | 2.03e-06 | 383 | 33 | 7 | GO:0048608 | |
| GeneOntologyBiologicalProcess | reproductive system development | 2.21e-06 | 388 | 33 | 7 | GO:0061458 | |
| GeneOntologyBiologicalProcess | male gonad development | 7.26e-06 | 171 | 33 | 5 | GO:0008584 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 7.47e-06 | 172 | 33 | 5 | GO:0046546 | |
| GeneOntologyBiologicalProcess | hemopoiesis | RBMY1D RBMY1B RBMY1E TJP2 KAT7 CCN4 CTNNB1 ARID1A RC3H1 RBMY1A1 | 1.37e-05 | 1223 | 33 | 10 | GO:0030097 |
| GeneOntologyBiologicalProcess | sex differentiation | 1.78e-05 | 352 | 33 | 6 | GO:0007548 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 2.45e-05 | 561 | 33 | 7 | GO:0048568 | |
| GeneOntologyBiologicalProcess | gonad development | 9.42e-05 | 292 | 33 | 5 | GO:0008406 | |
| GeneOntologyBiologicalProcess | development of primary sexual characteristics | 1.02e-04 | 297 | 33 | 5 | GO:0045137 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 1.14e-04 | 59 | 33 | 3 | GO:0000381 | |
| GeneOntologyBiologicalProcess | embryonic epithelial tube formation | 1.17e-04 | 159 | 33 | 4 | GO:0001838 | |
| GeneOntologyBiologicalProcess | epithelial tube formation | 1.62e-04 | 173 | 33 | 4 | GO:0072175 | |
| GeneOntologyBiologicalProcess | tube formation | 2.18e-04 | 187 | 33 | 4 | GO:0035148 | |
| GeneOntologyBiologicalProcess | neural plate development | 2.23e-04 | 14 | 33 | 2 | GO:0001840 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 2.32e-04 | 190 | 33 | 4 | GO:0016331 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 2.45e-04 | 1390 | 33 | 9 | GO:0045944 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 2.66e-04 | 197 | 33 | 4 | GO:0002244 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 2.72e-04 | 79 | 33 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | skeletal system development | 3.82e-04 | 615 | 33 | 6 | GO:0001501 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast proliferation | 4.17e-04 | 19 | 33 | 2 | GO:2000288 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 4.83e-04 | 906 | 33 | 7 | GO:0043009 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 5.35e-04 | 237 | 33 | 4 | GO:0019827 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 5.62e-04 | 929 | 33 | 7 | GO:0009792 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 5.79e-04 | 242 | 33 | 4 | GO:0098727 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | 6.53e-04 | 1256 | 33 | 8 | GO:0051726 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system morphogenesis | 6.98e-04 | 109 | 33 | 3 | GO:0048704 | |
| GeneOntologyBiologicalProcess | neural tube closure | 7.75e-04 | 113 | 33 | 3 | GO:0001843 | |
| GeneOntologyBiologicalProcess | tube closure | 7.95e-04 | 114 | 33 | 3 | GO:0060606 | |
| GeneOntologyBiologicalProcess | negative regulation of chondrocyte differentiation | 8.50e-04 | 27 | 33 | 2 | GO:0032331 | |
| GeneOntologyBiologicalProcess | regulation of stem cell proliferation | 9.00e-04 | 119 | 33 | 3 | GO:0072091 | |
| GeneOntologyBiologicalProcess | spinal cord development | 9.00e-04 | 119 | 33 | 3 | GO:0021510 | |
| GeneOntologyBiologicalProcess | primary neural tube formation | 9.22e-04 | 120 | 33 | 3 | GO:0014020 | |
| GeneOntologyBiologicalProcess | embryonic brain development | 9.81e-04 | 29 | 33 | 2 | GO:1990403 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 9.81e-04 | 29 | 33 | 2 | GO:2000819 | |
| GeneOntologyBiologicalProcess | cell fate specification | 9.91e-04 | 123 | 33 | 3 | GO:0001708 | |
| GeneOntologyBiologicalProcess | regulation of myoblast proliferation | 1.19e-03 | 32 | 33 | 2 | GO:2000291 | |
| GeneOntologyBiologicalProcess | neural tube formation | 1.27e-03 | 134 | 33 | 3 | GO:0001841 | |
| GeneOntologyBiologicalProcess | osteoblast differentiation | 1.32e-03 | 302 | 33 | 4 | GO:0001649 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | 1.41e-03 | 789 | 33 | 6 | GO:0002521 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 1.51e-03 | 36 | 33 | 2 | GO:0061037 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 1.56e-03 | 540 | 33 | 5 | GO:1903706 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 1.69e-03 | 148 | 33 | 3 | GO:0048706 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 1.79e-03 | 151 | 33 | 3 | GO:1902106 | |
| GeneOntologyBiologicalProcess | stem cell proliferation | 1.96e-03 | 156 | 33 | 3 | GO:0072089 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 2.05e-03 | 42 | 33 | 2 | GO:0070316 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 2.07e-03 | 159 | 33 | 3 | GO:1903707 | |
| GeneOntologyBiologicalProcess | myoblast proliferation | 2.15e-03 | 43 | 33 | 2 | GO:0051450 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 2.18e-03 | 162 | 33 | 3 | GO:0030316 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 2.24e-03 | 349 | 33 | 4 | GO:0014706 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 2.25e-03 | 44 | 33 | 2 | GO:0045023 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 2.28e-03 | 351 | 33 | 4 | GO:0048562 | |
| GeneOntologyBiologicalProcess | central nervous system development | 2.46e-03 | 1197 | 33 | 7 | GO:0007417 | |
| GeneOntologyCellularComponent | spliceosomal complex | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBMX RBMY1A1 RBMY1C RBMY1F | 3.39e-11 | 215 | 33 | 9 | GO:0005681 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RBMY1D RBMY1B RBMY1E KAT7 CTNNB1 RBMXL3 ARID1A RBMXL1 THRAP3 MED12 RBMX RBMY1A1 RBMY1C RBMY1F | 6.78e-09 | 1377 | 33 | 14 | GO:0140513 |
| GeneOntologyCellularComponent | ribonucleoprotein complex | RBMY1D MRPS15 RBMY1B RBMY1E RPL24 RBMXL3 RBMXL1 RBMX RBMY1A1 RBMY1C RBMY1F | 1.22e-06 | 1194 | 33 | 11 | GO:1990904 |
| GeneOntologyCellularComponent | male germ cell nucleus | 9.97e-06 | 86 | 33 | 4 | GO:0001673 | |
| GeneOntologyCellularComponent | supraspliceosomal complex | 1.45e-05 | 4 | 33 | 2 | GO:0044530 | |
| GeneOntologyCellularComponent | germ cell nucleus | 2.93e-05 | 113 | 33 | 4 | GO:0043073 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 4.36e-04 | 94 | 33 | 3 | GO:0044291 | |
| GeneOntologyCellularComponent | bicellular tight junction | 1.14e-03 | 131 | 33 | 3 | GO:0005923 | |
| GeneOntologyCellularComponent | tight junction | 1.36e-03 | 139 | 33 | 3 | GO:0070160 | |
| GeneOntologyCellularComponent | mediator complex | 1.55e-03 | 37 | 33 | 2 | GO:0016592 | |
| GeneOntologyCellularComponent | apical junction complex | 1.96e-03 | 158 | 33 | 3 | GO:0043296 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | 4.28e-05 | 772 | 19 | 7 | MP:0014259 | |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | 4.53e-05 | 779 | 19 | 7 | MP:0014257 | |
| MousePheno | embryonic lethality between implantation and somite formation, complete penetrance | 4.75e-05 | 311 | 19 | 5 | MP:0011096 | |
| MousePheno | absent third pharyngeal arch | 4.88e-05 | 8 | 19 | 2 | MP:0010642 | |
| MousePheno | embryonic lethality between implantation and somite formation | 7.26e-05 | 340 | 19 | 5 | MP:0006205 | |
| MousePheno | abnormal pharyngeal arch morphology | 7.26e-05 | 171 | 19 | 4 | MP:0002884 | |
| MousePheno | abnormal mandibular prominence morphology | 7.83e-05 | 10 | 19 | 2 | MP:0010939 | |
| MousePheno | embryonic lethality prior to organogenesis | 9.42e-05 | 1204 | 19 | 8 | MP:0013292 | |
| MousePheno | absent mesoderm | 9.65e-05 | 67 | 19 | 3 | MP:0001683 | |
| MousePheno | abnormal maxillary prominence morphology | 1.15e-04 | 12 | 19 | 2 | MP:0010940 | |
| MousePheno | embryonic lethality prior to tooth bud stage | 2.50e-04 | 1383 | 19 | 8 | MP:0013293 | |
| MousePheno | abnormal third pharyngeal arch morphology | 2.95e-04 | 19 | 19 | 2 | MP:0006339 | |
| MousePheno | abnormal embryonic tissue morphology | 4.34e-04 | 1116 | 19 | 7 | MP:0002085 | |
| MousePheno | embryonic lethality between implantation and placentation, complete penetrance | 4.65e-04 | 506 | 19 | 5 | MP:0011095 | |
| MousePheno | kinked tail | 4.65e-04 | 114 | 19 | 3 | MP:0000585 | |
| MousePheno | forebrain hypoplasia | 4.75e-04 | 24 | 19 | 2 | MP:0000784 | |
| MousePheno | absent heartbeat | 5.15e-04 | 25 | 19 | 2 | MP:0004086 | |
| MousePheno | failure to gastrulate | 5.28e-04 | 119 | 19 | 3 | MP:0001696 | |
| MousePheno | abnormal foot pad morphology | 5.58e-04 | 26 | 19 | 2 | MP:0000574 | |
| MousePheno | absent pharyngeal arches | 6.02e-04 | 27 | 19 | 2 | MP:0003874 | |
| MousePheno | abnormal mesoderm morphology | 6.38e-04 | 127 | 19 | 3 | MP:0014141 | |
| MousePheno | abnormal second pharyngeal arch morphology | 6.95e-04 | 29 | 19 | 2 | MP:0006338 | |
| MousePheno | ocular hypertelorism | 6.95e-04 | 29 | 19 | 2 | MP:0001300 | |
| MousePheno | embryonic lethality between implantation and placentation | 7.69e-04 | 565 | 19 | 5 | MP:0009850 | |
| MousePheno | abnormal developmental patterning | 8.46e-04 | 577 | 19 | 5 | MP:0002084 | |
| MousePheno | embryonic growth arrest | 1.06e-03 | 346 | 19 | 4 | MP:0001730 | |
| MousePheno | asymmetric rib joints | 1.26e-03 | 39 | 19 | 2 | MP:0000155 | |
| MousePheno | abnormal germ layer morphology | 1.27e-03 | 161 | 19 | 3 | MP:0014138 | |
| MousePheno | belly spot | 1.39e-03 | 41 | 19 | 2 | MP:0000373 | |
| MousePheno | abnormal optic cup morphology | 1.46e-03 | 42 | 19 | 2 | MP:0004269 | |
| MousePheno | abnormal neural tube closure | 1.48e-03 | 378 | 19 | 4 | MP:0003720 | |
| MousePheno | abnormal embryo development | 1.49e-03 | 1370 | 19 | 7 | MP:0001672 | |
| MousePheno | small pharyngeal arch | 1.60e-03 | 44 | 19 | 2 | MP:0006346 | |
| Domain | RBM1CTR | 1.71e-19 | 8 | 32 | 7 | PF08081 | |
| Domain | RBM1CTR | 1.71e-19 | 8 | 32 | 7 | IPR012604 | |
| Domain | RRM_1 | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 RBMX RBMY1A1 RBMY1F | 4.98e-11 | 208 | 32 | 9 | PF00076 |
| Domain | RRM | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 RBMX RBMY1A1 RBMY1F | 7.27e-11 | 217 | 32 | 9 | SM00360 |
| Domain | RRM_dom | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 RBMX RBMY1A1 RBMY1F | 1.09e-10 | 227 | 32 | 9 | IPR000504 |
| Domain | RRM | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 RBMX RBMY1A1 RBMY1F | 1.22e-10 | 230 | 32 | 9 | PS50102 |
| Domain | Nucleotide-bd_a/b_plait | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 RBMX RBMY1A1 RBMY1F | 3.39e-10 | 258 | 32 | 9 | IPR012677 |
| Domain | - | 6.07e-09 | 244 | 32 | 8 | 3.30.70.330 | |
| Domain | - | 5.38e-04 | 222 | 32 | 4 | 1.25.10.10 | |
| Domain | RRM_dom_euk | 7.04e-04 | 23 | 32 | 2 | IPR003954 | |
| Domain | RRM_1 | 7.04e-04 | 23 | 32 | 2 | SM00361 | |
| Domain | ARM-like | 1.12e-03 | 270 | 32 | 4 | IPR011989 | |
| Domain | Arm | 1.28e-03 | 31 | 32 | 2 | PF00514 | |
| Domain | ARM | 2.13e-03 | 40 | 32 | 2 | SM00185 | |
| Domain | ARM_REPEAT | 2.13e-03 | 40 | 32 | 2 | PS50176 | |
| Domain | Armadillo | 2.93e-03 | 47 | 32 | 2 | IPR000225 | |
| Domain | ARM-type_fold | 1.99e-02 | 339 | 32 | 3 | IPR016024 | |
| Pathway | WP_MRNA_PROCESSING | 1.34e-06 | 451 | 27 | 8 | MM15946 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.57e-04 | 10 | 27 | 2 | MM14956 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.92e-04 | 11 | 27 | 2 | M9990 | |
| Pathway | REACTOME_FORMATION_OF_AXIAL_MESODERM | 3.17e-04 | 14 | 27 | 2 | M46441 | |
| Pubmed | 3.15e-18 | 7 | 33 | 6 | 8269511 | ||
| Pubmed | 4.15e-16 | 12 | 33 | 6 | 9598316 | ||
| Pubmed | 3.36e-15 | 6 | 33 | 5 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 1.17e-14 | 7 | 33 | 5 | 8875892 | |
| Pubmed | 7.17e-13 | 13 | 33 | 5 | 10749975 | ||
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 1.67e-12 | 15 | 33 | 5 | 14762062 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 3.35e-12 | 5 | 33 | 4 | 8817321 | |
| Pubmed | 3.35e-12 | 5 | 33 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 3.35e-12 | 5 | 33 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 3.35e-12 | 5 | 33 | 4 | 19737860 | |
| Pubmed | 1.01e-11 | 6 | 33 | 4 | 18239052 | ||
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 1.01e-11 | 6 | 33 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 1.01e-11 | 6 | 33 | 4 | 12356914 | |
| Pubmed | 1.01e-11 | 6 | 33 | 4 | 9499427 | ||
| Pubmed | 1.01e-11 | 6 | 33 | 4 | 15051956 | ||
| Pubmed | 2.35e-11 | 7 | 33 | 4 | 17001072 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 2.35e-11 | 7 | 33 | 4 | 10377282 | |
| Pubmed | 4.69e-11 | 8 | 33 | 4 | 7479793 | ||
| Pubmed | 1.40e-10 | 10 | 33 | 4 | 10601091 | ||
| Pubmed | 1.40e-10 | 10 | 33 | 4 | 9384609 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 3.31e-10 | 12 | 33 | 4 | 20543856 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 4.77e-10 | 13 | 33 | 4 | 23816659 | |
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 6.68e-10 | 14 | 33 | 4 | 14611631 | |
| Pubmed | RBMY evolved on the Y chromosome from a ubiquitously transcribed X-Y identical gene. | 7.78e-10 | 3 | 33 | 3 | 10391207 | |
| Pubmed | 1.01e-09 | 347 | 33 | 8 | 16033648 | ||
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 1.58e-09 | 17 | 33 | 4 | 28115466 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 2.04e-09 | 18 | 33 | 4 | 12023983 | |
| Pubmed | 9.89e-09 | 26 | 33 | 4 | 35920200 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MRPS15 KAT7 RPL24 ARID1A THRAP3 MED12 RBMX PKP4 TUBGCP3 SON SEC16A | 2.61e-08 | 1353 | 33 | 11 | 29467282 |
| Pubmed | 9.30e-08 | 10 | 33 | 3 | 10332027 | ||
| Pubmed | 2.10e-07 | 274 | 33 | 6 | 34244482 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 2.18e-07 | 695 | 33 | 8 | 23602568 | |
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 2.21e-07 | 55 | 33 | 4 | 19468303 | |
| Pubmed | TEAD4 regulates KRT8 and YAP in preimplantation embryos in mice but not in cattle. | 2.81e-07 | 14 | 33 | 3 | 38206180 | |
| Pubmed | 2.95e-07 | 59 | 33 | 4 | 11279525 | ||
| Pubmed | TJP2 PPHLN1 CTNNB1 RBMXL3 RBM23 THRAP3 RBMX TUBGCP3 SON SEC16A | 3.54e-07 | 1371 | 33 | 10 | 36244648 | |
| Pubmed | 3.92e-07 | 503 | 33 | 7 | 16964243 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 5.20e-07 | 1082 | 33 | 9 | 38697112 | |
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 8.73e-07 | 2 | 33 | 2 | 32473614 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 37542030 | ||
| Pubmed | 9.44e-07 | 844 | 33 | 8 | 25963833 | ||
| Pubmed | 9.69e-07 | 847 | 33 | 8 | 35850772 | ||
| Pubmed | 1.01e-06 | 80 | 33 | 4 | 25662211 | ||
| Pubmed | 1.69e-06 | 1247 | 33 | 9 | 27684187 | ||
| Pubmed | 2.01e-06 | 95 | 33 | 4 | 24029230 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.22e-06 | 411 | 33 | 6 | 35182466 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 27391264 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 16936073 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 34458856 | ||
| Pubmed | RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet. | 2.62e-06 | 3 | 33 | 2 | 17188681 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 18006828 | ||
| Pubmed | The candidate spermatogenesis gene RBMY has a homologue on the human X chromosome. | 2.62e-06 | 3 | 33 | 2 | 10391206 | |
| Pubmed | Direct interaction of Alzheimer's disease-related presenilin 1 with armadillo protein p0071. | 2.62e-06 | 3 | 33 | 2 | 10092585 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 12165565 | ||
| Pubmed | Exclusion of PTEN, CTNNB1, and PTCH as candidate genes for Birt-Hogg-Dube syndrome. | 2.62e-06 | 3 | 33 | 2 | 11836379 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 16565090 | ||
| Pubmed | A new Cre driver mouse line, Tcf21/Pod1-Cre, targets metanephric mesenchyme. | 2.62e-06 | 3 | 33 | 2 | 22792366 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23316072 | ||
| Pubmed | Primary cilia and Gli3 activity regulate cerebral cortical size. | 2.80e-06 | 29 | 33 | 3 | 21976438 | |
| Pubmed | The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. | 3.10e-06 | 241 | 33 | 5 | 12815422 | |
| Pubmed | 3.97e-06 | 713 | 33 | 7 | 29802200 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 4.01e-06 | 714 | 33 | 7 | 28302793 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 4.38e-06 | 1038 | 33 | 8 | 26673895 | |
| Pubmed | Sox9 Controls Self-Renewal of Oncogene Targeted Cells and Links Tumor Initiation and Invasion. | 5.23e-06 | 4 | 33 | 2 | 26095047 | |
| Pubmed | Constitutional and functional genetics of human alcohol-related hepatocellular carcinoma. | 5.23e-06 | 4 | 33 | 2 | 28296015 | |
| Pubmed | VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer. | 5.23e-06 | 4 | 33 | 2 | 28051067 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 20508033 | ||
| Pubmed | SAFB1, an RBMX-binding protein, is a newly identified regulator of hepatic SREBP-1c gene. | 5.23e-06 | 4 | 33 | 2 | 19403048 | |
| Pubmed | A mouse model of the most aggressive subgroup of human medulloblastoma. | 5.23e-06 | 4 | 33 | 2 | 22340591 | |
| Pubmed | 7.51e-06 | 40 | 33 | 3 | 28323616 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 10037471 | ||
| Pubmed | Tissue-specific roles of Fgfr2 in development of the external genitalia. | 8.72e-06 | 5 | 33 | 2 | 26081573 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 38489371 | ||
| Pubmed | Beta-catenin activation is necessary and sufficient to specify the dorsal dermal fate in the mouse. | 8.72e-06 | 5 | 33 | 2 | 16730693 | |
| Pubmed | 1.16e-05 | 549 | 33 | 6 | 38280479 | ||
| Pubmed | Overexpression of Sonic Hedgehog suppresses embryonic hair follicle morphogenesis. | 1.31e-05 | 6 | 33 | 2 | 14597196 | |
| Pubmed | Signaling systems affecting the severity of multiple osteochondromas. | 1.31e-05 | 6 | 33 | 2 | 29545125 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.48e-05 | 157 | 33 | 4 | 30686591 | |
| Pubmed | 1.67e-05 | 162 | 33 | 4 | 25796446 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.76e-05 | 1257 | 33 | 8 | 36526897 | |
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 23454480 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 16678815 | ||
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 1.97e-05 | 169 | 33 | 4 | 23084401 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.10e-05 | 358 | 33 | 5 | 32460013 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.19e-05 | 361 | 33 | 5 | 26167880 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 2.43e-05 | 626 | 33 | 6 | 33644029 | |
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 18579725 | ||
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 37885410 | ||
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 29103956 | ||
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 11821434 | ||
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 2.44e-05 | 59 | 33 | 3 | 28813667 | |
| Pubmed | 2.99e-05 | 188 | 33 | 4 | 29721183 | ||
| Pubmed | 3.08e-05 | 653 | 33 | 6 | 22586326 | ||
| Pubmed | Patched1 functions as a gatekeeper by promoting cell cycle progression. | 3.13e-05 | 9 | 33 | 2 | 16489008 | |
| Pubmed | Ectodysplasin A1 promotes placodal cell fate during early morphogenesis of ectodermal appendages. | 3.13e-05 | 9 | 33 | 2 | 15371307 | |
| Pubmed | Role of canonical Wnt signaling/ß-catenin via Dermo1 in cranial dermal cell development. | 3.13e-05 | 9 | 33 | 2 | 20980404 | |
| Pubmed | Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. | 3.13e-05 | 9 | 33 | 2 | 8710870 | |
| Pubmed | Regulation of the Wnt signaling pathway by disabled-2 (Dab2). | 3.13e-05 | 9 | 33 | 2 | 12805222 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 3.29e-05 | 989 | 33 | 7 | 36424410 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 3.80e-05 | 678 | 33 | 6 | 30209976 | |
| Interaction | RBMY1E interactions | 1.45e-08 | 4 | 32 | 3 | int:RBMY1E | |
| Interaction | ECT2 interactions | TJP2 RPL24 CTNNB1 RBMXL3 ARID1A RBMXL1 RBM23 THRAP3 RBMX SON SEC16A | 6.23e-08 | 887 | 32 | 11 | int:ECT2 |
| Interaction | RBMY1J interactions | 1.21e-07 | 29 | 32 | 4 | int:RBMY1J | |
| Interaction | RBMY1F interactions | 2.98e-07 | 36 | 32 | 4 | int:RBMY1F | |
| Interaction | RBM39 interactions | MRPS15 TJP2 RPL24 PPHLN1 CTNNB1 RBM23 THRAP3 RC3H1 RBMX SON SEC16A | 3.17e-07 | 1042 | 32 | 11 | int:RBM39 |
| Interaction | KIF20A interactions | TJP2 RPL24 PPHLN1 CTNNB1 RBMXL1 RBM23 THRAP3 RBMX PKP4 SON SEC16A | 3.49e-07 | 1052 | 32 | 11 | int:KIF20A |
| Interaction | RBMX interactions | 4.58e-07 | 461 | 32 | 8 | int:RBMX | |
| Interaction | MATR3 interactions | 5.50e-07 | 655 | 32 | 9 | int:MATR3 | |
| Interaction | SNRPA interactions | 6.41e-07 | 482 | 32 | 8 | int:SNRPA | |
| Interaction | SRSF6 interactions | 8.84e-07 | 503 | 32 | 8 | int:SRSF6 | |
| Interaction | CLK3 interactions | 1.13e-06 | 220 | 32 | 6 | int:CLK3 | |
| Interaction | PRR3 interactions | 2.16e-06 | 246 | 32 | 6 | int:PRR3 | |
| Interaction | MEN1 interactions | 2.66e-06 | 1029 | 32 | 10 | int:MEN1 | |
| Interaction | PRPF19 interactions | 5.48e-06 | 450 | 32 | 7 | int:PRPF19 | |
| Interaction | PCDHB14 interactions | 5.49e-06 | 22 | 32 | 3 | int:PCDHB14 | |
| Interaction | CIRBP interactions | 5.66e-06 | 164 | 32 | 5 | int:CIRBP | |
| Interaction | SRSF4 interactions | 6.77e-06 | 300 | 32 | 6 | int:SRSF4 | |
| Interaction | TOP1 interactions | 9.80e-06 | 696 | 32 | 8 | int:TOP1 | |
| Interaction | GLDC interactions | 9.96e-06 | 321 | 32 | 6 | int:GLDC | |
| Interaction | EZH1 interactions | 1.33e-05 | 92 | 32 | 4 | int:EZH1 | |
| Interaction | PRC1 interactions | 1.41e-05 | 973 | 32 | 9 | int:PRC1 | |
| Interaction | SRSF3 interactions | 1.44e-05 | 522 | 32 | 7 | int:SRSF3 | |
| Interaction | LINC02910 interactions | 1.51e-05 | 95 | 32 | 4 | int:LINC02910 | |
| Interaction | RBMY1A1 interactions | 1.75e-05 | 32 | 32 | 3 | int:RBMY1A1 | |
| Interaction | LUZP4 interactions | 1.77e-05 | 99 | 32 | 4 | int:LUZP4 | |
| Interaction | BTRC interactions | 2.13e-05 | 775 | 32 | 8 | int:BTRC | |
| Interaction | KIF23 interactions | 2.24e-05 | 1031 | 32 | 9 | int:KIF23 | |
| Interaction | SFPQ interactions | 2.35e-05 | 563 | 32 | 7 | int:SFPQ | |
| Interaction | POU5F1 interactions | 2.97e-05 | 584 | 32 | 7 | int:POU5F1 | |
| Interaction | MCM2 interactions | 3.25e-05 | 1081 | 32 | 9 | int:MCM2 | |
| Interaction | YAP1 interactions | 3.60e-05 | 1095 | 32 | 9 | int:YAP1 | |
| Interaction | GATA4 interactions | 4.01e-05 | 411 | 32 | 6 | int:GATA4 | |
| Interaction | HNRNPC interactions | 5.00e-05 | 634 | 32 | 7 | int:HNRNPC | |
| Interaction | EED interactions | TJP2 RPL24 PPHLN1 CTNNB1 ARID1A THRAP3 RBMX PKP4 TUBGCP3 SON | 5.21e-05 | 1445 | 32 | 10 | int:EED |
| Interaction | CIT interactions | 5.36e-05 | 1450 | 32 | 10 | int:CIT | |
| Interaction | SCRIB interactions | 5.80e-05 | 266 | 32 | 5 | int:SCRIB | |
| Interaction | THRAP3 interactions | 6.08e-05 | 443 | 32 | 6 | int:THRAP3 | |
| Interaction | TNRC6A interactions | 7.40e-05 | 280 | 32 | 5 | int:TNRC6A | |
| Interaction | GAGE5 interactions | 7.62e-05 | 52 | 32 | 3 | int:GAGE5 | |
| Interaction | SRRM2 interactions | 7.67e-05 | 462 | 32 | 6 | int:SRRM2 | |
| Interaction | SSRP1 interactions | 8.15e-05 | 685 | 32 | 7 | int:SSRP1 | |
| Interaction | IFI6 interactions | 8.54e-05 | 54 | 32 | 3 | int:IFI6 | |
| Interaction | APOBEC3D interactions | 8.56e-05 | 148 | 32 | 4 | int:APOBEC3D | |
| Interaction | FBXW11 interactions | 8.74e-05 | 473 | 32 | 6 | int:FBXW11 | |
| Interaction | CFAP141 interactions | 9.02e-05 | 55 | 32 | 3 | int:CFAP141 | |
| Interaction | VASP interactions | 9.31e-05 | 294 | 32 | 5 | int:VASP | |
| Interaction | NANOG interactions | 9.58e-05 | 481 | 32 | 6 | int:NANOG | |
| Interaction | SRPK2 interactions | 1.08e-04 | 717 | 32 | 7 | int:SRPK2 | |
| Interaction | HNRNPM interactions | 1.14e-04 | 723 | 32 | 7 | int:HNRNPM | |
| Interaction | KLF4 interactions | 1.16e-04 | 160 | 32 | 4 | int:KLF4 | |
| Interaction | SNRNP70 interactions | 1.16e-04 | 984 | 32 | 8 | int:SNRNP70 | |
| Interaction | CHMP4B interactions | 1.18e-04 | 727 | 32 | 7 | int:CHMP4B | |
| Interaction | AR interactions | 1.22e-04 | 992 | 32 | 8 | int:AR | |
| Interaction | RBM3 interactions | 1.24e-04 | 163 | 32 | 4 | int:RBM3 | |
| Interaction | MECP2 interactions | 1.26e-04 | 1287 | 32 | 9 | int:MECP2 | |
| Interaction | LZTS2 interactions | 1.35e-04 | 512 | 32 | 6 | int:LZTS2 | |
| Interaction | CPSF6 interactions | 1.56e-04 | 526 | 32 | 6 | int:CPSF6 | |
| Interaction | APOBEC3C interactions | 2.11e-04 | 187 | 32 | 4 | int:APOBEC3C | |
| Interaction | DIMT1 interactions | 2.19e-04 | 189 | 32 | 4 | int:DIMT1 | |
| Interaction | SRPK3 interactions | 2.24e-04 | 190 | 32 | 4 | int:SRPK3 | |
| Interaction | HNF1B interactions | 2.24e-04 | 190 | 32 | 4 | int:HNF1B | |
| Interaction | KCTD13 interactions | 2.31e-04 | 1394 | 32 | 9 | int:KCTD13 | |
| Interaction | SRSF1 interactions | 2.41e-04 | 570 | 32 | 6 | int:SRSF1 | |
| Interaction | CLK2 interactions | 2.47e-04 | 195 | 32 | 4 | int:CLK2 | |
| Interaction | WWP2 interactions | 2.88e-04 | 840 | 32 | 7 | int:WWP2 | |
| Interaction | CSNK1A1 interactions | 3.11e-04 | 381 | 32 | 5 | int:CSNK1A1 | |
| Interaction | HNRNPK interactions | 3.16e-04 | 853 | 32 | 7 | int:HNRNPK | |
| Interaction | PHGDH interactions | 3.26e-04 | 385 | 32 | 5 | int:PHGDH | |
| Interaction | CDH12 interactions | 3.27e-04 | 17 | 32 | 2 | int:CDH12 | |
| Interaction | GNL2 interactions | 3.30e-04 | 386 | 32 | 5 | int:GNL2 | |
| Interaction | RB1CC1 interactions | 3.34e-04 | 387 | 32 | 5 | int:RB1CC1 | |
| Interaction | USP54 interactions | 3.40e-04 | 212 | 32 | 4 | int:USP54 | |
| Interaction | PRRC2A interactions | 3.42e-04 | 389 | 32 | 5 | int:PRRC2A | |
| Interaction | CDK6 interactions | 3.58e-04 | 215 | 32 | 4 | int:CDK6 | |
| Interaction | PAN2 interactions | 3.76e-04 | 397 | 32 | 5 | int:PAN2 | |
| Interaction | CLK1 interactions | 3.84e-04 | 219 | 32 | 4 | int:CLK1 | |
| Interaction | NEDD1 interactions | 3.98e-04 | 221 | 32 | 4 | int:NEDD1 | |
| Interaction | CEP126 interactions | 4.02e-04 | 91 | 32 | 3 | int:CEP126 | |
| Interaction | UBE2A interactions | 4.33e-04 | 226 | 32 | 4 | int:UBE2A | |
| Interaction | KHDRBS3 interactions | 4.42e-04 | 94 | 32 | 3 | int:KHDRBS3 | |
| Interaction | FOXC1 interactions | 4.47e-04 | 228 | 32 | 4 | int:FOXC1 | |
| Interaction | MCM5 interactions | 4.86e-04 | 420 | 32 | 5 | int:MCM5 | |
| Interaction | FBXW7 interactions | 4.88e-04 | 1215 | 32 | 8 | int:FBXW7 | |
| Interaction | SRSF7 interactions | 5.13e-04 | 425 | 32 | 5 | int:SRSF7 | |
| Interaction | RNPS1 interactions | 5.13e-04 | 425 | 32 | 5 | int:RNPS1 | |
| Interaction | PRMT1 interactions | 5.29e-04 | 929 | 32 | 7 | int:PRMT1 | |
| Interaction | CDH8 interactions | 5.53e-04 | 22 | 32 | 2 | int:CDH8 | |
| Interaction | RC3H2 interactions | 5.58e-04 | 667 | 32 | 6 | int:RC3H2 | |
| Interaction | HNRNPA1 interactions | 5.86e-04 | 945 | 32 | 7 | int:HNRNPA1 | |
| Interaction | OGT interactions | 6.04e-04 | 950 | 32 | 7 | int:OGT | |
| Interaction | ANKRD50 interactions | 6.63e-04 | 108 | 32 | 3 | int:ANKRD50 | |
| Interaction | RPA4 interactions | 6.78e-04 | 452 | 32 | 5 | int:RPA4 | |
| Interaction | TRIM31 interactions | 6.92e-04 | 454 | 32 | 5 | int:TRIM31 | |
| Interaction | RPL10 interactions | 7.30e-04 | 702 | 32 | 6 | int:RPL10 | |
| Interaction | WWP1 interactions | 7.33e-04 | 260 | 32 | 4 | int:WWP1 | |
| Interaction | MAGOH interactions | 7.76e-04 | 264 | 32 | 4 | int:MAGOH | |
| Interaction | DDX21 interactions | 8.22e-04 | 718 | 32 | 6 | int:DDX21 | |
| Interaction | SIGLEC12 interactions | 8.36e-04 | 27 | 32 | 2 | int:SIGLEC12 | |
| Interaction | ZNF677 interactions | 8.36e-04 | 27 | 32 | 2 | int:ZNF677 | |
| Interaction | SRPK1 interactions | 8.64e-04 | 477 | 32 | 5 | int:SRPK1 | |
| Cytoband | Yq11.223 | 6.94e-09 | 93 | 33 | 5 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 2.81e-06 | 311 | 33 | 5 | chrYq11 | |
| Cytoband | 1p34.3 | 9.22e-04 | 62 | 33 | 2 | 1p34.3 | |
| GeneFamily | RNA binding motif containing | RBMY1D RBMY1B RBMY1E RBMXL3 RBMXL1 RBM23 RBMX RBMY1A1 RBMY1C RBMY1F | 1.17e-13 | 213 | 25 | 10 | 725 |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.60e-03 | 43 | 25 | 2 | 409 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 7.30e-08 | 33 | 32 | 4 | MM701 | |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 2.63e-07 | 45 | 32 | 4 | MM763 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_100 | 5.27e-05 | 50 | 31 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_200 | 1.34e-04 | 181 | 31 | 4 | gudmap_developingGonad_e11.5_testes_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.91e-04 | 595 | 31 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_100 | 2.75e-04 | 87 | 31 | 3 | gudmap_developingGonad_e11.5_testes_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_100 | 3.04e-04 | 90 | 31 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_200 | 3.24e-04 | 92 | 31 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k1_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200 | 4.02e-04 | 99 | 31 | 3 | gudmap_developingGonad_e11.5_testes_k5_200 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.54e-06 | 166 | 30 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| Drug | azafagomine | 1.57e-08 | 57 | 32 | 5 | CID011957435 | |
| Drug | hydantoin-5-propionic acid | 1.89e-08 | 21 | 32 | 4 | CID000000782 | |
| Drug | AZFd | 2.79e-08 | 23 | 32 | 4 | CID000196489 | |
| Drug | SU6668 | 4.48e-08 | 70 | 32 | 5 | CID000206042 | |
| Drug | Vistar | 1.83e-07 | 36 | 32 | 4 | CID000040896 | |
| Drug | 2-chlorodideoxyadenosine | 3.82e-07 | 43 | 32 | 4 | CID000072194 | |
| Drug | PKI166 | 5.99e-07 | 48 | 32 | 4 | CID006918403 | |
| Drug | HgCl | 6.51e-07 | 49 | 32 | 4 | CID000024182 | |
| Drug | thioglycolate | 2.31e-06 | 67 | 32 | 4 | CID000001133 | |
| Drug | p11-13 | 3.64e-06 | 75 | 32 | 4 | CID000015759 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.65e-06 | 185 | 32 | 5 | 5882_DN | |
| Drug | bipy | 1.02e-05 | 97 | 32 | 4 | CID000001474 | |
| Drug | 2-oyl | 1.39e-05 | 105 | 32 | 4 | CID000657137 | |
| Drug | carbonyl sulfide | 2.06e-05 | 116 | 32 | 4 | CID000010039 | |
| Drug | glutamin | 3.87e-05 | 461 | 32 | 6 | CID000000738 | |
| Drug | ara-AC | 4.09e-05 | 279 | 32 | 5 | CID000001805 | |
| Drug | oligoadenylate | 6.73e-05 | 157 | 32 | 4 | CID000107918 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 9.80e-05 | 173 | 32 | 4 | 4237_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.05e-04 | 176 | 32 | 4 | 1212_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 1.19e-04 | 182 | 32 | 4 | 1891_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 1515_DN | |
| Drug | tetraethylenepentamine pentahydrochloride; Down 200; 100uM; ssMCF7; HG-U133A | 1.68e-04 | 199 | 32 | 4 | 498_DN | |
| Drug | 5-aza-2'-deoxycytidine | 2.30e-04 | 638 | 32 | 6 | CID000016886 | |
| Disease | Malignant neoplasm of breast | 2.97e-05 | 1074 | 26 | 7 | C0006142 | |
| Disease | Adrenocortical carcinoma | 1.13e-04 | 18 | 26 | 2 | C0206686 | |
| Disease | Primary microcephaly | 1.71e-04 | 22 | 26 | 2 | C0431350 | |
| Disease | stomach cancer (is_marker_for) | 2.62e-04 | 142 | 26 | 3 | DOID:10534 (is_marker_for) | |
| Disease | Bilateral Wilms Tumor | 2.99e-04 | 29 | 26 | 2 | C2930471 | |
| Disease | Nephroblastoma | 4.62e-04 | 36 | 26 | 2 | C0027708 | |
| Disease | Malignant neoplasm of brain | 5.15e-04 | 38 | 26 | 2 | C0153633 | |
| Disease | Brain Neoplasms | 5.42e-04 | 39 | 26 | 2 | C0006118 | |
| Disease | Adult Medulloblastoma | 6.59e-04 | 43 | 26 | 2 | C0278876 | |
| Disease | Childhood Medulloblastoma | 6.59e-04 | 43 | 26 | 2 | C0278510 | |
| Disease | Melanotic medulloblastoma | 6.59e-04 | 43 | 26 | 2 | C1275668 | |
| Disease | Medullomyoblastoma | 6.59e-04 | 43 | 26 | 2 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 6.59e-04 | 43 | 26 | 2 | C0751291 | |
| Disease | Gastrointestinal Stromal Sarcoma | 7.88e-04 | 47 | 26 | 2 | C3179349 | |
| Disease | Salivary Gland Neoplasms | 7.88e-04 | 47 | 26 | 2 | C0036095 | |
| Disease | obesity (implicated_via_orthology) | 8.76e-04 | 215 | 26 | 3 | DOID:9970 (implicated_via_orthology) | |
| Disease | Gastrointestinal Stromal Tumors | 8.91e-04 | 50 | 26 | 2 | C0238198 | |
| Disease | Medulloblastoma | 8.91e-04 | 50 | 26 | 2 | C0025149 | |
| Disease | stomach cancer (is_implicated_in) | 1.84e-03 | 72 | 26 | 2 | DOID:10534 (is_implicated_in) | |
| Disease | Endometrial Carcinoma | 1.84e-03 | 72 | 26 | 2 | C0476089 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.30e-03 | 301 | 26 | 3 | DOID:684 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGRTYYSPVYRSPNH | 416 | Q99569 | |
| HRGLYCDYSGDRPRY | 96 | O95388 | |
| YAPPSRGYAYRDNGH | 231 | P0DJD3 | |
| RDYAPPSRGHAYRDY | 266 | P0DJD3 | |
| YAPPSRGYAYRDNGH | 231 | A6NDE4 | |
| RDYAPPSRGHAYRDY | 266 | A6NDE4 | |
| YAPPSRGYAYRDNGH | 231 | P0DJD4 | |
| RDYAPPSRGHAYRDY | 266 | P0DJD4 | |
| YAPPSRGYAYRDNGH | 231 | P0C7P1 | |
| RDYAPPSRGHAYRDY | 266 | P0C7P1 | |
| YAPPSRGYAYRDNGH | 231 | A6NEQ0 | |
| RDYAPPSRGHAYRDY | 266 | A6NEQ0 | |
| YAPPSRGYAYRDNGH | 231 | Q15415 | |
| RDYAPPSRGHAYRDY | 266 | Q15415 | |
| YPSHYDGRRVYPAPS | 666 | Q5TC82 | |
| YRSPPLATGYRYGHS | 126 | Q86U06 | |
| PPPRDYTYRDYGHSS | 236 | P38159 | |
| RQHYPYGGPYDRVRT | 1276 | O14497 | |
| GPSHPDTSYYIRYRG | 331 | Q96JP0 | |
| PLGYRQDDPSYRSFH | 706 | P35222 | |
| YHSPYPEEYARLGRL | 351 | O95251 | |
| YHTHLRPRPRAYYLE | 1726 | Q93074 | |
| ALPRDAHSTPYYYAR | 121 | Q96CW5 | |
| PAHGAADTAYPYGYR | 91 | Q00056 | |
| LDRPGEGSYNRYYSH | 41 | Q8NEY8 | |
| GIEYTFPPLYYRRAH | 186 | P82914 | |
| PPPRDYTYRDYGHSS | 236 | Q96E39 | |
| RAAAPDRDYLHRPSY | 41 | Q13635 | |
| RARHLRDYPDYKYRP | 106 | O60248 | |
| RDFRGHNRGYRRPYY | 71 | Q9Y2W1 | |
| YERAYSPEYRRGARH | 261 | Q9UDY2 | |
| LRDYSRRYYGHSSVP | 256 | Q8N7X1 | |
| RRYYGHSSVPDYRPL | 261 | Q8N7X1 | |
| YKIYPGHGRRYARTD | 11 | P83731 | |
| EPRYRPYDGAASAYA | 1196 | O15027 | |
| RYENGHYSYRIHRSP | 351 | Q15561 | |
| YHYRYEQDADPRRAP | 351 | P0DKB5 | |
| YYVSRLYGPSEPHSR | 91 | Q8IUK5 | |
| GRPHYYVSYRRNAFA | 386 | Q8WY21 | |
| YRLAQDPYRLGHDPY | 921 | P18583 |